Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Holz FG, Iida T, Maruko I, Sadda SR, et al. A CONSENSUS ON RISK MITIGATION FOR BROLUCIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Patient Selection, Evaluation, and Treatment. Retina 2022;42:1629-1637.
PMID: 35994582


Privacy Policy